Associations of PGK1 promoter hypomethylation and PGK1‐mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan‐cancer analysis

Wiley - 2019
Fei Shao1,2,3, Xueying Yang2, Wei Wang2, Juhong Wang2, Wei Guo2, Xiaoli Feng4, Susheng Shi4, Qi Xue2, Shugeng Gao2, Yibo Gao2, Zhimin Lu5,1, Jie He2
1Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310029 Zhejiang, P. R. China
2Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuannanli, Chaoyang District, Beijing, 100021 P. R. China
3Qingdao Cancer Institute, Cancer Institute of The Affiliated Hospital of Qingdao University, Qingdao, 266003 Shandong, P. R. China
4Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021 P. R. China
5State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021 P. R. China

Tóm tắt

AbstractBackgroundCancer cells reprogram metabolism for proliferation. Phosphoglycerate kinase 1 (PGK1), as a glycolytic enzyme and newly identified protein kinase, coordinates glycolysis and mitochondrial metabolism. However, the clinical significance of PGK1 expression and function in cancer progression is unclear. Here, we investigated the relationship between the progression and prognosis of multiple cancer types and PGK1 expression and its function in the mitochondrial metabolism regulation.MethodsWe performed pan‐cancer analyses of PGK1 mRNA level and DNA methylation in 11,908 tumor tissues and 1582 paired normal tissues across 34 cancer types in The Cancer Genome Atlas datasets. Using specific antibodies against PGK1 S203 and PDHK1 T338 phosphorylation, we performed immunohistochemistry with tissue microarray assay in additional 818 cancer cases with 619 paired normal tissues from five cancer types.ResultsThe PGK1 mRNA level was significantly elevated with hypomethylation in promotor regions and associated with advanced TNM stage in 15 and four cancer types, respectively. In breast carcinoma, elevated PGK1 mRNA level and promoter hypomethylation were associated with poor prognosis. Positively correlated PGK1 S203 and PDHK1 T338 phosphorylation levels were significantly associated with short overall survival (OS) in cancers of the breast, liver, lung, stomach, and esophagus and with advanced TNM stage in breast and esophageal cancers. PGK1 pS203 and PDHK1 pT338 were also independent predictors of short OS in liver, lung, and stomach cancer.ConclusionsThe elevated expression, promoter hypomethylation, and phosphorylation of PGK1 and PDHK1 were related with disease progression and short OS in diverse types of cancer. PGK1 and PDHK1 phosphorylation may be potential prognostic biomarkers.

Từ khóa


Tài liệu tham khảo

10.1016/j.cell.2008.08.021

10.1038/nrc3038

10.1126/science.1160809

10.1016/j.cell.2011.02.013

10.1016/j.tibs.2018.01.006

10.1016/0012‐1606(92)90056‐M

10.1038/s41580‐018‐0029‐7

10.1186/s40880‐018‐0335‐7

10.1074/mcp.M400221‐MCP200

10.1111/j.1755‐5949.2012.00353.x

10.3892/ijo.2013.1971

10.1002/pmic.200500345

10.1002/ijc.24835

10.1016/j.molcel.2016.02.009

10.1016/j.molcel.2017.01.027

10.1016/j.gene.2017.07.056

10.1002/jcp.26531

10.1016/j.molcel.2018.09.007

10.1186/1471‐2105‐11‐587

10.3322/caac.21492

10.1111/j.1365‐2141.1976.tb03563.x

10.7326/0003‐4819‐103‐4‐620

10.7326/0003‐4819‐103‐3‐460

10.1111/j.1365‐2141.1991.tb04444.x

10.1182/blood‐2012‐10‐462440

10.1038/nrg3270

10.1038/nrg3230

10.1016/j.tibs.2018.01.006

10.1038/s41580‐018‐0029‐7

10.1186/s13046‐018‐0789‐0

10.1186/s13046‐015‐0221‐y

10.1038/nature25003

10.1186/s40880‐018‐0336‐6

10.1080/15384101.2016.1179037

10.1016/j.cell.2012.07.018

10.1038/ncb2629

10.1126/sciadv.aav4570

10.1002/hep.28887

10.1371/journal.pbio.1002243

10.1186/s40880‐018‐0302‐3

10.1186/s13046‐018‐0758‐7

10.1056/NEJMoa0808710

10.1200/JCO.2010.28.3762

10.1093/annonc/mdw013

10.1200/JCO.2009.21.9832

Thông tin
Thông tin xuất bản

Wiley

Thông tin tác giả